Invention Grant
- Patent Title: Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity
-
Application No.: US16434220Application Date: 2019-06-07
-
Publication No.: US10590107B2Publication Date: 2020-03-17
- Inventor: Adam D. Hughes , Daniel Byun , Yan Chen , Melissa Fleury , John R. Jacobsen , Eric Stangeland , Richard D. Wilson , Rose Yen
- Applicant: Theravance Respiratory Company, LLC
- Applicant Address: US CA South San Francisco
- Assignee: Theravance Respiratory Company, LLC
- Current Assignee: Theravance Respiratory Company, LLC
- Current Assignee Address: US CA South San Francisco
- Agent Robert J. Smith
- Main IPC: C07D401/12
- IPC: C07D401/12 ; A61K31/444 ; A61K31/56 ; A61K45/06 ; A61K31/4709
Abstract:
The invention relates to a pharmaceutical composition comprising an isotonic aqueous solution comprising a compound of formula I: or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20190300504A1 Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity Public/Granted day:2019-10-03
Information query
